Development stage healthcare delivery company HOPE Therapeutics Inc, a subsidiary of NRx Pharmaceuticals Inc (Nasdaq:NRXP), announced on Monday that it has appointed BTIG, a financial services company specialising in investment banking, institutional trading, research and related brokerage services, as its financial advisor.

The scope of the engagement includes advisory and assistance in evaluating strategic and financing options available to the company and identification, evaluation and negotiation of potential acquisition targets for the HOPE network of clinics, as well as equity and debt financing structures.

The company recently announced execution of an agreement for USD27m in funding for HOPE clinic acquisition. Upon closing of the first tranche of the anticipated financing, the company intends to leverage the investment with proposed bank debt and similar instruments to fund its initial rollup of Interventional Psychiatry Clinics.